PH25091A - Active stubstance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin - Google Patents

Active stubstance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin

Info

Publication number
PH25091A
PH25091A PH36635A PH36635A PH25091A PH 25091 A PH25091 A PH 25091A PH 36635 A PH36635 A PH 36635A PH 36635 A PH36635 A PH 36635A PH 25091 A PH25091 A PH 25091A
Authority
PH
Philippines
Prior art keywords
skin
active
controlled administration
active substances
plaster
Prior art date
Application number
PH36635A
Other languages
English (en)
Inventor
Hans Rainer Hoffmann
Peter Barth
Karin Wolter
Gunther Simon
Original Assignee
Lts Lohmann Therapie Steme Gmb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Steme Gmb filed Critical Lts Lohmann Therapie Steme Gmb
Publication of PH25091A publication Critical patent/PH25091A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H37/00—Accessories for massage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
PH36635A 1987-04-28 1988-03-14 Active stubstance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin PH25091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873714140 DE3714140A1 (de) 1987-04-28 1987-04-28 Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut

Publications (1)

Publication Number Publication Date
PH25091A true PH25091A (en) 1991-02-19

Family

ID=6326433

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36635A PH25091A (en) 1987-04-28 1988-03-14 Active stubstance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin

Country Status (28)

Country Link
EP (1) EP0288734B1 (da)
JP (1) JP2683264B2 (da)
KR (1) KR910002250B1 (da)
AT (1) ATE69962T1 (da)
AU (1) AU627422B2 (da)
CA (1) CA1316062C (da)
CZ (1) CZ278969B6 (da)
DD (1) DD281349A5 (da)
DE (2) DE3714140A1 (da)
DK (1) DK166193C (da)
ES (1) ES2027720T3 (da)
FI (1) FI91599C (da)
GR (1) GR3003289T3 (da)
HR (1) HRP920828B1 (da)
HU (1) HU204203B (da)
IE (1) IE61005B1 (da)
IL (1) IL85859A (da)
MY (1) MY103355A (da)
NO (1) NO172278C (da)
NZ (1) NZ223894A (da)
PH (1) PH25091A (da)
PL (1) PL161617B1 (da)
PT (1) PT87345B (da)
SI (1) SI8810781B (da)
SK (1) SK278466B6 (da)
WO (1) WO1988008318A1 (da)
YU (1) YU47056B (da)
ZA (1) ZA881739B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE3844247A1 (de) * 1988-12-29 1990-07-12 Minnesota Mining & Mfg Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4110027C2 (de) * 1991-03-27 1996-08-29 Lohmann Therapie Syst Lts Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
FR2728463A1 (fr) * 1994-12-21 1996-06-28 Lhd Lab Hygiene Dietetique Systeme transdermique d'administration simultanee de plusieurs principes actifs
DE29514849U1 (de) * 1995-09-15 1995-11-16 Weyergans Rudolf Cellulitis-Pflaster
FR2749514B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament
DE19820999A1 (de) * 1998-05-11 1999-11-18 Lohmann Therapie Syst Lts Laminat zum Aufbringen auf einen Akzeptor
DE19911262C2 (de) * 1999-03-13 2003-04-10 Scs Skin Care Systems Gmbh Vorrichtung zur Abgabe kosmetischer Wirkstoffe
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
GB2383282B (en) 2002-04-02 2004-06-16 Crane Electronics Torque sensing tool
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
EP2000119A1 (en) * 2007-06-08 2008-12-10 Royal College of Surgeons in Ireland Wound dressings
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
JP5386205B2 (ja) * 2009-03-19 2014-01-15 リンテック株式会社 経皮吸収型貼付剤
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
AU2016381351B2 (en) * 2015-12-30 2022-09-29 Corium, Inc. Systems and methods for long term transdermal administration
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297995A (en) * 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device

Also Published As

Publication number Publication date
CA1316062C (en) 1993-04-13
ES2027720T3 (es) 1992-06-16
DK722888A (da) 1988-12-23
NO884530D0 (no) 1988-10-11
SI8810781B (sl) 1999-04-30
WO1988008318A1 (en) 1988-11-03
GR3003289T3 (en) 1993-02-17
IL85859A0 (en) 1988-09-30
PL161617B1 (pl) 1993-07-30
NO884530L (no) 1988-11-03
FI91599C (fi) 1994-07-25
CZ278969B6 (en) 1994-11-16
EP0288734B1 (de) 1991-12-04
DE3866582D1 (de) 1992-01-16
NO172278C (no) 1993-06-30
DD281349A5 (de) 1990-08-08
DK166193B (da) 1993-03-22
HRP920828B1 (en) 1998-02-28
PT87345A (pt) 1989-05-12
EP0288734A1 (de) 1988-11-02
PL272134A1 (en) 1989-05-16
DE3714140C2 (da) 1989-03-09
SK288388A3 (en) 1997-06-04
HUT53294A (en) 1990-10-28
MY103355A (en) 1993-06-30
FI886019A (fi) 1988-12-28
AU1489488A (en) 1988-12-02
JPH01503383A (ja) 1989-11-16
KR910002250B1 (ko) 1991-04-08
NO172278B (no) 1993-03-22
ZA881739B (da) 1988-08-31
DK722888D0 (da) 1988-12-23
IL85859A (en) 1992-11-15
IE880834L (en) 1988-10-28
YU78188A (en) 1989-12-31
HU204203B (en) 1991-12-30
DE3714140A1 (de) 1988-11-10
CZ288388A3 (en) 1994-04-13
IE61005B1 (en) 1994-09-07
NZ223894A (en) 1990-11-27
PT87345B (pt) 1995-03-01
ATE69962T1 (de) 1991-12-15
AU627422B2 (en) 1992-08-27
SI8810781A (en) 1996-12-31
YU47056B (sh) 1994-12-28
SK278466B6 (en) 1997-06-04
HRP920828A2 (hr) 1994-04-30
DK166193C (da) 1993-08-16
KR890700375A (ko) 1989-04-24
FI91599B (fi) 1994-04-15
JP2683264B2 (ja) 1997-11-26

Similar Documents

Publication Publication Date Title
PH25091A (en) Active stubstance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
DE3475692D1 (en) Drug delivery device
AU1379988A (en) Transdermal drug delivery device with dual permeation enhancers
ZA891949B (en) Reservoir for controlled active substance delivery,apparatus containing the same,as well as method for its manufacture and use of the apparatus
GR3002566T3 (en) Dermal and transdermal therapeutic system having a discontinuous-pattern adhesive layer and method of manufacturing thereof